Fenofibrate for patients with asymptomatic primary biliary cirrhosis
about
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysisPeroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study.Concept on the pathogenesis and treatment of primary biliary cirrhosisFenofibrate in primary biliary cirrhosis: a pilot study.Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrateNuclear receptors as drug targets in cholestatic liver diseases.Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrate.Proposed therapies in primary biliary cholangitis.Natural history and management of primary biliary cirrhosis.The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression.Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.PPARα activation protects against cholestatic liver injury.Effect of fenofibrate in combination with urate lowering agents in patients with gout.Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come.Fenofibrate-induced liver injury.Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.
P2860
Q27023986-F2AFF310-B3FC-4F5E-8B14-D05D5808DFFDQ33307635-80A8D14F-08A7-4A91-B2CB-538000E81AC5Q33866454-03956FB8-864B-4FBF-836B-EB6480DB241AQ33912957-2997DF73-CD27-4639-BA4E-DF591F3BBF56Q36338007-D86A9538-68BA-4F15-BE9D-3A450ACA7EEBQ36786270-3DE03E1C-0A78-4D68-BE44-F274D8FE741EQ36834217-A9EEBBE4-826C-43BA-834A-2F17F4586017Q37072380-AF570A7E-4C9E-47DA-857A-100F207CBED0Q37355843-4E94A9B0-5340-41FF-800A-29F949F59661Q37356791-1AE9FE44-C11E-424D-A6EF-92C9BDECBB7EQ39047912-B70B2871-91D3-4C1C-A6CE-99779C82B07DQ41565916-14EB2D74-C2BC-4AAF-A1AE-9D9A64673D55Q41869801-25C6AEEB-6872-456F-AEC5-4FE2754FD5F3Q42649890-C3AC5673-515E-427F-BC9B-FAC418851ACAQ43067830-043E632E-4484-4373-94AC-34E47D7B8795Q55190939-F2329D7D-1C37-4230-8ECF-E442A7928519
P2860
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@ast
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@en
type
label
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@ast
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@en
prefLabel
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@ast
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@en
P2093
P2860
P356
P1476
Fenofibrate for patients with asymptomatic primary biliary cirrhosis
@en
P2093
Hiromi Ishibashi
Kazufumi Dohmen
Kyosuke Yamamoto
Makoto Nakamuta
Naoya Shimohashi
Toshihiko Mizuta
P2860
P304
P356
10.3748/WJG.V10.I6.894
P407
P577
2004-03-01T00:00:00Z